Skip to main content

CombiMatrix to Start Trading as CBMX Sept. 13

This article has been updated from a previous version to correct the ticker symbol in the headline.
 
NEW YORK (GenomeWeb News) — CombiMatrix’ stock tomorrow will begin trading on the Nasdaq exchange under its new ticker symbol “CBMX,” the company said today.
 
CombiMatrix had been trading under the symbol “CBMXD” during a 21-day trading period following the company’s split from parent Acacia Research on Aug 15.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.